Resource Guide

Fabrus, founded in 2007 as the first company in Pfizer's La Jolla incubator to develop a next generation antibody discovery platform that expands the...

The Chemistry Research Solution, LLC (TCRS) has ample experience in providing antibody-drug conjugate (ADC) related services to its clients. Currently, the company is engaged...

Evonik Industries, a German based global leader in specialty chemicals, offers the strength and breadth that comes with working with one of the world's...

Traditional cytotoxic cancer chemotherapies kill rapidly dividing cancer and normal cells in an indiscriminate manner.  this leads to significant toxicity in patients being treated....

ThioLogics is a new biotechnology company that has developed a groundbreaking site-specific conjugation platform that will enable the assembly of the next generation of...

Eisai Co., Ltd., together with it's research institute (the KAN Research Institute, Inc. or KRI) aims to discover and develop new drugs based on novel...

CytomX is a biotechnology company developing the next generation of highly targeted antibody therapeutics. The company's Probody™ Platform represents an approach designed to develop empowered...

Covagen AG is a clinical stage company that develops bispecific FynomAbs by fusing its human Fynomer binding proteins to antibodies resulting in therapeutics with novel...

Concortis Biosystems, Corp is a biotechnology company creating next generation biotherapeutics using proprietary conjugation technologies and novel drug delivery systems, including antibody-drug conjugates (ADCs). ADCs...

Coldstream Laboratories, Inc., turns pharmaceutical development ideas into safe, pure, and effective pharmaceutical dosage forms. Since 2007, the company has delivered unique solutions to complex development...